Skip to content

Clinical trials

Phase 3 Colorectal Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Colorectal Neoplasms Phase: Phase 3 Country / region: United States Clear all

114 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20013
200311
20042
20055
20065
20072
20086
20092
20109
20111
20121
20136
20142
20164
20183
20195
20205
20215
20225
20244
20253
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed64
Terminated21
Recruiting15
Active, not recruiting8
Unknown status5
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alliance for Clinical Trials in Oncology13
Hoffmann-La Roche6
Amgen5
Pfizer5
SWOG Cancer Research Network5
Sanofi5
NSABP Foundation Inc4
Eli Lilly and Company3
Exelixis3
Janssen Research & Development, LLC3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Colorectal Neoplasms114
Colonic Neoplasms48
Rectal Neoplasms39
Neoplasm Metastasis12
Neoplasms8
Gastrointestinal Neoplasms4
Adenomatous Polyps3
Breast Neoplasms3
Carcinoma, Non-Small-Cell Lung3
Colonic Diseases3

Trials

Showing 1 to 25 of 114. Each trial links to its page on Pharma Observatory.

14 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.